Google's got some explaining to do

Google's earnings results are in, and they're not the prettiest

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Google's (NASDAQ: GOOG) earnings results are in, and they're not the prettiest. The company missed expectations by a wide margin and shares took a tumble. Whenever this happens, it's often wise to dig deeper and see if there's an underlying issue.

The disappointment
In the second quarter, Big G reported year over year revenue growth of 19% to US$14.11 billion, which translated to a non-GAAP income of US$3.23 billion, or US$9.56 a share. Analysts were expecting Google to earn US$10.78 a share on revenue of US$14.42 billion. The culprit appears to be that Google's cost-per-click — or CPC — declined by 2% sequentially and 6% year over year, despite paid click volume rising by 23% year over year and 4% sequentially. This could indicate there's potentially a structural headwind that's driving down the CPC metric.

The dig
Whenever something earnings-related doesn't add up, the first place to look for answers is the conference call. Unfortunately, this is all that Patrick Pichette, Google's CFO, had to formally say on the matter:

"Our aggregate cost-per-paid was down 6% year over year and down 2% quarter over quarter and currency fluctuations in this case had a minimal effect in Q2 CPC growth, and yet our monetisation metrics continued to be affected by the usual factors that we've discussed many times including geographic mix, channel mix, property mix, our product and policy changes as well as FX [currency fluctuations]."

When questioned later on about if mobile was to blame for the soft CPC, Pichette acknowledged that mobile played a role, but he didn't elaborate to what degree. However, he did add that considering CPC alone is "dangerous" and should be incorporated with paid click volume to get a better sense of the health of the business. Naturally, the combined metrics for the quarter has the company made the company "very pleased."

Getting theoretical
Larry Kim, founder and CTO of online advertising specialist WordStream, has a few theories on what could be pressuring CPC. Of the five listed, I think three could be in play here, perhaps in some combination of each other. The first possibility could be that ad inventory is increasing faster than demand and the added supply is pressuring CPC. The second could be that mobile clicks are growing faster than their desktop counterpart, and since CPC is a weighted average between the two, it's dragging down the average.

The final theory could be that Google's recently launched AdWords enhanced campaigns are so incredibly effective that marketers need to spend less on a per-click basis to achieve their desired results. If this were to be the case, it would mean that advertisers are likely thrilled to spend less money on a per-click basis, which could ultimately drive new advertising spending on the platform longer term. In other words, this seemingly negative transition to enhanced campaigns would be rather short-lived.

A watchful eye
Truth be told, one quarter of potential trouble isn't enough for me to say there's a major issue going on with Google's business. Investors should still continue to monitor the situation by keeping an eye on Google's future earnings results. Ultimately, Google's long-term success will be dependent on its ability to drive future advertising spending by offering an ever-improving user experience for both the user and marketer alike. Could it be that Google is getting too good at its job and it's actually hurting the bottom line?

The Australian Financial Review says "good quality Australian shares that have a long history of paying dividends are a real alternative to a term deposit." Get "3 Stocks for the Great Dividend Boom" in our special FREE report. Click here now to find out the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading

A version of this article, written by Steve Heller, originally appeared on fool.com.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »